同济大学长聘体系预聘副教授，博士生导师，上海市浦江人才计划获得者。同济大学和美国 Mayo Clinic联合培养博士,曾获得2022年度“同济大学优秀出站博士后”称号；主持国家自然科学基金面上项目以及青年项目各1项；省部级课题3项，以第一或共同作者身份在国际著名期刊Science advances, Cancer letters, Nature Cell biology, Nature Cancer发表SCI论文十余篇,申请专利两项。
Associate Professor and doctoral supervisor of School of Medicine of Tongji University, recipient of the Shanghai Pujiang Program. Tongji University and Mayo Clinic jointly trained PhD；He was also awarded the title of "Outstanding Postdoctoral Fellow of Tongji University" in 2022; He has presided one general project and one youth project from the National Natural Science Foundation of China (NSFC) and three provincial and ministerial level projects, and has published over 10 SCI papers as the first or co author in internationally renowned journals such as Science Advancements, Cancer Letters, Nature Cell biology, and Nature Cancer et al., and applied for two patents.
